Evidence map›Paper›PMID 36902094›Full record

ArticleInternational journal of molecular sciences2023

Overexpression of a Novel Noxo1 Mutant Increases Ros Production and Noxo1 Relocalisation.

Fatima-Zahra Benssouina, Fabrice Parat, Claude Villard, Ludovic Leloup, Françoise Garrouste, Jean-Marc Sabatier, Lotfi Ferhat, Hervé Kovacic

Open access · goldFull text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  3. Neurodegenerative Diseases: Molecular Mechanisms and Therapies.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fatima-Zahra BenssouinaAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Fabrice ParatAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Claude VillardAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Ludovic LeloupAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.ORCID 0000-0001-9369-5689
Françoise GarrousteAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Jean-Marc SabatierAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Lotfi FerhatAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.
Hervé KovacicAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, 13005 Marseille, France.ORCID 0000-0001-6509-4210
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noxo1, the organizing element of the Nox1-dependent NADPH oxidase complex responsible for producing reactive oxygen species, has been described to be degraded by the proteasome. We mutated a D-box in Noxo1 to express a protein with limited degradation and capable of maintaining Nox1 activation. Wild-type (wt) and mutated Noxo1 (mut1) proteins were expressed in different cell lines to characterize their phenotype, functionality, and regulation. Mut1 increases ROS production through Nox1 activity affects mitochondrial organization and increases cytotoxicity in colorectal cancer cell lines. Unexpectedly the increased activity of Noxo1 is not related to a blockade of its proteasomal degradation since we were unable in our conditions to see any proteasomal degradation either for wt or mut1 Noxo1. Instead, D-box mutation mut1 leads to an increased translocation from the membrane soluble fraction to a cytoskeletal insoluble fraction compared to wt Noxo1. This mut1 localization is associated in cells with a filamentous phenotype of Noxo1, which is not observed with wt Noxo1. We found that mut1 Noxo1 associates with intermediate filaments such as keratin 18 and vimentin. In addition, Noxo1 D-Box mutation increases Nox1-dependent NADPH oxidase activity. Altogether, Nox1 D-box does not seem to be involved in Noxo1 degradation but rather related to the maintenance of the Noxo1 membrane/cytoskeleton balance.

Indexed as

Adaptor Proteins, Signal TransducingReactive Oxygen SpeciesCell Line, TumorHumansMutationNADPH Oxidase 1Adaptor Proteins, Signal TransducingNADPH Oxidase 1NOXO1 protein, humanReactive Oxygen SpeciesD-BoxNADPH oxidaseNox1Noxo1proteasomeRac1reactive oxygen species

Identifiers

PMID36902094
PMCPMC10003393
OpenAlexW4322629311

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read97
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.